Hence, we studied whether FOXO1 activation of the HBP1 promoter is also under the control of the upstream regulator Akt in the HSC-3 oral cancer cell line with an aberrant activation of the EGFR/PI3K pathway [23]. The gene discussed is HBP1; the disease is lip and oral cavity carcinoma.